BMY R&D Expense Growth

Bristol Myers Squibb · R&D Expense Growth

BMY logo

BMY R&D Expense Growth

Latest reported-10.83%
BMY FY R&D Growth (YoY) (0.00% → -10.83%)
High-resolution chart · PNG

BMY r&d expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
-10.8253%
20.0022%
-2.2084%
-6.7288%
-8.5076%
81.2459%
-2.9059%
-2.1027%
29.0503%
-15.3378%
30.569%
21.5224%
-4.4314%
1.6931%
7.6556%
-2.221%
3.844%
7.0079%
9.7292%
11.6878%
7.12%
9.6972%
3.3092%
1.0536%
12.5838%
10.2331%
16.7995%
8.7365%
8.5423%
6.422%
8.213%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.